AU2001258481A1 - Omp protein associated with autologous and/or heterologous tumour cell lysate - Google Patents

Omp protein associated with autologous and/or heterologous tumour cell lysate

Info

Publication number
AU2001258481A1
AU2001258481A1 AU2001258481A AU5848101A AU2001258481A1 AU 2001258481 A1 AU2001258481 A1 AU 2001258481A1 AU 2001258481 A AU2001258481 A AU 2001258481A AU 5848101 A AU5848101 A AU 5848101A AU 2001258481 A1 AU2001258481 A1 AU 2001258481A1
Authority
AU
Australia
Prior art keywords
autologous
cell lysate
tumour cell
protein associated
omp protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258481A
Inventor
Jean-Yves Bonnefoy
Isabelle Invernizzi
Toufic Renno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2001258481A1 publication Critical patent/AU2001258481A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001258481A 2000-05-04 2001-05-03 Omp protein associated with autologous and/or heterologous tumour cell lysate Abandoned AU2001258481A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0005702A FR2808445A1 (en) 2000-05-04 2000-05-04 OMP PROTEIN ASSOCIATED WITH A LYSATE OF AUTOLOGOUS AND / OR HETEROLOGOUS TUMOR CELLS
FR0005702 2000-05-04
PCT/FR2001/001348 WO2001082959A1 (en) 2000-05-04 2001-05-03 Omp protein associated with autologous and/or heterologous tumour cell lysate

Publications (1)

Publication Number Publication Date
AU2001258481A1 true AU2001258481A1 (en) 2001-11-12

Family

ID=8849889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258481A Abandoned AU2001258481A1 (en) 2000-05-04 2001-05-03 Omp protein associated with autologous and/or heterologous tumour cell lysate

Country Status (4)

Country Link
EP (1) EP1278539A1 (en)
AU (1) AU2001258481A1 (en)
FR (1) FR2808445A1 (en)
WO (1) WO2001082959A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428028A2 (en) * 2001-09-14 2004-06-16 Reinhard Zeidler Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726472B1 (en) * 1994-11-07 1997-01-31 Pf Medicament CARRIER WITH ADJUVANT EFFECT, IMMUNOGENIC COMPLEX CONTAINING THE SAME, PREPARATION METHOD THEREOF, NUCLEOTIDE SEQUENCE AND VACCINE
FR2789588B1 (en) * 1999-02-17 2001-05-04 Pf Medicament USE OF AN OMPA ENTEROBACTERIA PROTEIN ASSOCIATED WITH AN ANTIGEN IN A PHARMACEUTICAL COMPOSITION FOR GENERATING OR INCREASING ANTIVIRAL, PEST CONTROL OR ANTITUMOR CYTOTOXIC RESPONSE
FR2790960B1 (en) * 1999-03-15 2002-10-31 Pf Medicament USE OF BACTERIAL MEMBRANE FRACTIONS WITH IMMUNOSTIMULANT ACTIVITY IN THE TREATMENT OF CANCERS, THEIR PREPARATION METHODS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO2001082959A1 (en) 2001-11-08
EP1278539A1 (en) 2003-01-29
FR2808445A1 (en) 2001-11-09

Similar Documents

Publication Publication Date Title
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU6058500A (en) Fusion protein and uses thereof
AU2001254885A1 (en) Modified ES cells and ES cell-specific gene
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU5132199A (en) Electroporation buffer with cryprotective capabilities
AU2002322519A1 (en) Proteins associated with cell growth, differentiation, and death
AU2002323110A1 (en) Proteins associated with cell growth, differentiation, and death
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU2001273208A1 (en) Proteins associated with aging
AU2001258481A1 (en) Omp protein associated with autologous and/or heterologous tumour cell lysate
AU2002236984A1 (en) Proteins associated with cell growth, differentiation, and death
AU4771600A (en) Cells, culture methods and their uses
AU2002320022A1 (en) Proteins associated with cell growth, differentiation, and death
AU1197001A (en) B cell clonal toxins and methods for using the same
AU2002320089A1 (en) Proteins associated with cell growth, differentiation, and death
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001260633A1 (en) Fas ligand-fused proteins
AU2001288940A1 (en) Gene and sequence variation associated with cancer
AU2002330157A1 (en) Proteins associated with cell growth, differentiation, and death
AU2002240889A1 (en) Proteins that interact with betatrcp
AU2001274563A1 (en) Novel polypeptide and its dna
AU2001276899A1 (en) Mammalian mdm2 binding proteins and uses thereof
AU2002227373A1 (en) Proteins associated with cell growth, differentiation, and death
AU2001261423A1 (en) Vasodilator-thrombolytic fusion proteins and conjugates